Limited research exists on the effects of C1-INH on comorbidities, though one study investigated the association between the type of HAE treatment (i.e., C1-INH replacement therapy for both on-demand and prophylaxis use) and comorbidities [31]. This evidence concerns the gene SERPING1 and hereditary angioedema.